PAPER Lester E, Ooi FK, Bakkar N, Ayers J, Woerman AL, Wheeler J, Bowser R, Carlson GA, Prusiner SB, Parker R
SEARCH RESULTS
19634 RESULTS
Peter Lansbury on Advisory Committee Again Urges FDA to Vote No on Aducanumab
COMMENT Why doesn't Biogen take the learning from the first two trials and carefully design a trial that can support their contention of efficacy? If they are as certain as their press releases indicate (some of them targeting patients and their families), t
Maria Carrillo
Alz AssociationChicago, United States
Does Synchronizing Brain Waves Bring Harmony?
CONFERENCE COVERAGE 2021-04-14 Conference Coverage If enhancing memory with light and sound seems futuristic, then welcome to the future. Or so some scientists say. Results from four early stage clinical trials on mild Alzheimer’s disease were presented at the AD/PD 2021 conference, he
Carlos Pérez
Spain
PAPER Wen J, Chen CH, Stock A, Doerner J, Gulinello M, Putterman C
Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice.
Brain Behav Immun. 2016 May;54:27-37. Epub 2015 Dec 23 PubMed: 26721417Flora Angelo
FinanceUnited States
Melissa Rundle
Research FellowWinston-Salem, United States
Advisory Committee Again Urges FDA to Vote No on Aducanumab
COMMUNITY NEWS 2021-04-14 Community News Biogen’s licensing application for aducanumab has generated controversy throughout the Alzheimer’s field, with different voices clamoring for its approval or rejection. Now, three researchers who sat on the Food and Drug Administration’s ad
PAPER Morant AV, Jagalski V, Vestergaard HT
Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non-orphan, Non-oncology Drugs in the European Union and United States from 2012-2016.
Clin Transl Sci. 2019 Jul;12(4):361-370. Epub 2019 Mar 2 PubMed: 30681284PAPER Langlands G, Mackenzie J, Graham C, Watson N, Molesworth A, Summers D, Green A, Smith C, Pal S
Non-white cases of sporadic Creutzfeldt-Jakob disease: A 28 year review of United Kingdom National Surveillance Data.
J Neurol Sci. 2021 May 15;424:117416. Epub 2021 Mar 24 PubMed: 33839436PAPER Yang W, Deng B, Huang Y, Liu J, Huang Z, Chang Z, Zhu S, Chan LL, Chaudhuri KR, Tan EK, Wang Q
Two heterozygous progranulin mutations in progressive supranuclear palsy.
Brain. 2021 Apr 12;144(3):e27. PubMed: 33844830PAPER Oji Y, Hatano T, Funayama M, Hattori N
Reply: PSAP variants in Parkinson's disease: a large cohort study in Chinese mainland population.
Brain. 2021 Apr 12;144(3):e26. PubMed: 33844829PAPER Siddiqi B, Koemeter-Cox A
A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson's Research and Care.
J Parkinsons Dis. 2021;11(3):905-908. PubMed: 33843698PAPER Miyasaki JM, Lim TT, Bhidayasiri R
Editorial: Inclusion, equity, diversity and social justice in movement disorders research.
Parkinsonism Relat Disord. 2021 Apr;85:114-116. Epub 2021 Mar 26 PubMed: 33840573Current Filters
- Date Range : Apr 2020 to Apr 2021 x